Paul Rennie

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Paul Rennie
Paul Rennie
Executive Director, Managing Director, Executive Chairman / Paradigm Biopharmaceuticals

Paul Rennie has sales, marketing, business development, operational and IP commercialisation experience in the biopharmaceutical sector.

His experience includes working for Boehringer Mannheim (now Roche Diagnostics), Merck KGGA as national sales and marketing manager, and as director of business development at Soltec (FH Faulding).

Mr Rennie also led the commercialisation of Recaldent, a novel biopharmaceutical arising from research at the dental school, University of Melbourne.

He has worked in a number of positions with Mesoblast, and was the inaugural chief operating officer and executive vice president of new product development for the adult stem cell company.

Lists and Charts

Roles

Roles

2014
Executive Director, Managing Director, Executive Chairman
Paradigm Biopharmaceuticals
Year started and most recent title

Total Shareholder Return as at 02/12/24

Share Transactions

  • Person Activity

    NEWS: Tagged in Board Moves December 5, 2023 05 Dec 2023
    NEWS: Tagged in Board Moves August 31, 2023 31 Aug 2023
    NEWS: Tagged in NeuroScientific boss resigns after trial fail 09 Sep 2022
    Paul Rennie
    		NEW ROLE: Non-Executive Chair, NeuroScientific Biopharmaceuticals 22 Jun 2021
    Paul Rennie
    		NEW ROLE: Executive Director, Managing Director, Executive Chairman, Paradigm Biopharmaceuticals 03 Nov 2020

Related Information

Access to our data for Paul Rennie is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Paul Rennie is linked to 3 organisations which are included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.